UnknownNot Applicable

The Role of m6A RNA Modification in Moyamoya Disease

China160 participantsStarted 2021-01-01

Plain-language summary

The purpose of this study is to detect the change of m6A RNA modification from peripheral blood of patients with moyamoya disease, and to assess the relationship between clinical characteristics.

Who can participate

Age range4 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Health volunteers' inclusion criteria: Age between 4-60; Male or female; Exclusion criteria: Exclude the volunteers with history of cerebrovascular disease.

What they're measuring

m6A RNA modification in peripheral blood

Timeframe: 2021.1.1-2021.12.31

Trial details

NCT IDNCT04696094

SponsorBeijing Tiantan Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-31

Contact for this trial

Qian Zhang, MD

008613611075005 zhangqianchina@yahoo.com

View on ClinicalTrials.gov More Moyamoya Disease trials